Amaia Etxabe
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cellular and Structural Characterization of VP1 and VP2 Knockout Mutants of AAV3B Serotype and Implications for AAV Manufacturing.
Journal: Human gene therapy
Published: September 09, 2022
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML.
Journal: Scientific reports
Published: April 03, 2018
Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target.
Journal: Leukemia
Published: July 21, 2016
Repositioning of bromocriptine for treatment of acute myeloid leukemia.
Journal: Journal of translational medicine
Published: June 15, 2016
Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells.
Journal: Oncotarget
Published: February 24, 2016
Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma.
Journal: Cancer cell international
Published: October 16, 2015
CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia.
Journal: Haematologica
Published: February 01, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026